Extendicare Inc. (TSE:EXE – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The company traded as high as C$11.35 and last traded at C$11.31, with a volume of 84376 shares. The stock had previously closed at C$11.12.
Analyst Upgrades and Downgrades
EXE has been the topic of a number of research analyst reports. BMO Capital Markets set a C$11.00 price objective on Extendicare and gave the company a “market perform” rating in a research note on Thursday, January 30th. Royal Bank of Canada raised their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a research note on Thursday, November 28th. TD Securities lifted their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Finally, Cormark upgraded shares of Extendicare to a “moderate buy” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Extendicare currently has a consensus rating of “Hold” and an average target price of C$10.25.
Check Out Our Latest Analysis on EXE
Extendicare Trading Down 0.4 %
Extendicare Dividend Announcement
The firm also recently announced a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be given a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 4.16%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare’s dividend payout ratio (DPR) is 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- Want to Profit on the Downtrend? Downtrends, Explained.
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Calculate Stock Profit
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Investing in Construction Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.